Healthcare Professionals
Healthcare Professionals play a vital role in helping Cephalon discover, develop and deliver medicines that improve the lives of patients. Their clinical expertise is essential to identifying and providing answers to unmet medical needs. Healthcare professionals also help us assure patients have access to the medications they need and that those mediations are used correctly.
Below are a few of the ways in which Cephalon is working with its healthcare professional partners:
- Product and Scientific Information
- Clinical Development
- Commitment to Integrity and Transparency
- Reducing Prescription Drug Misuse
Understand our financial relationship with healthcare professionals.
Product and Scientific Information
Healthcare professionals need the latest, most accurate, available scientific information regarding our products to assure patient safety and therapeutic benefit. Cephalon provides healthcare professionals relevant information regarding our products and related therapeutic areas that is objective, data-driven and scientifically balanced. If you would like information about Cephalon products, please click here to fill out a Product Information Request form or contact Cephalon Medical Services directly at 1-800-896-5855.
Clinical Development
Cephalon continually researches experimental medicines through our clinical development program in the hope that the products we offer today can help improve patient health in unseen ways in the future. If you are interested in becoming an investigator for a Cephalon-sponsored study or initiating research on a Cephalon product, please click here to visit our clinical trials page.
Commitment to Integrity and Transparency
Cephalon fully supports transparency in our relationships with healthcare professionals as part of our effort to foster a better understanding of the critical role these vital relationships play in developing and bringing new medicines to market and in addressing the needs of patients.
Therefore, Cephalon has begun to make the financial nature of our relationships with healthcare professionals transparent to the public. In January 2010, we began posting fees Cephalon has made to healthcare professionals for speaking and consulting services for the previous 12 months. In March 2011, Cephalon plans to disclose all other items of value we provide to healthcare professionals, including meals and payments for participation in research studies. This disclosure will include all payments made from January 2010 onward.
Cephalon adheres to the code of conduct developed by PhRMA, a trade association representing the pharmaceutical industry. Called the PhRMA Code, it is intended to assure that pharmaceutical companies interact with healthcare professionals in a way that benefits patients and enhances the practice of medicine. Click here to learn about Cephalon’s commitment to appropriate interactions with healthcare professionals.
Reducing Prescription Drug Misuse
Cephalon has a long history of developing programs to minimize potential risks associated with inappropriate use of prescription opioid pain medications. In conjunction with FDA, we have developed risk evaluation and mitigation strategies (REMS) for our medications and are we are striving to apply new technologies to help make the REMS processes more accessible to patients, pharmacists and physicians. Also, our When Good Medicines Become Bad DrugsSM advocacy program educations patients, caregivers and the public about the safe and responsible use of prescription medicines.
Healthcare Professionals Play a Vital Role
Our mission is one we cannot successfully achieve alone. Cephalon relies on healthcare professionals for their expertise and to assure that patients have access to the medications they need and that those mediations are used correctly.